This post suggests how to use the client's emerging imagery, memories, and unconscious content during a psychedelic session ...
1don MSNOpinion
Psychedelic medicine is approaching a turning point. The US needs the right infrastructure to be ready
Today’s psychedelics bear little resemblance to 1970s counterparts. These medicines undergo rigorous clinical trials and ...
Congressional leaders Jack Bergman and Lou Correa called for the establishment of national standards and a regulatory ...
The original release states, "clinical psychologist" next to founder and it should read, "founder of and the Neurodivergent Empowerment Institute, and creator of Empowerment-Based Integrated Treatment ...
The watchdog wants psychedelic drug applications rejected. If any drug advances, it says it must be barred for minors, ...
The cover and title of Rich Haridy’s Trip Reports are reminiscent of a poster for a psychedelic rock band or a 1960s ...
A pharmaceutical company developing psychedelics as potential medicines recently opened its new United States headquarters in Jersey City, relocating from its former location in Manhattan. Compass ...
Daniel covers the intersection of the health industry and the federal government. He reports on corporate influence in government, the health consequences of federal policies, and the politics of ...
Food and Drug Administration (FDA) officials are laying out the agency’s “new framework” for psychedelic medicines, including steps that are taking to “make psychedelic therapies available to patients ...
Could hallucinogenic drugs become part of mainstream NHS care to treat depression?
Turn on, tune in, drop out: Christian Angermayer has cemented his place in psychedelics by selling biotech AtaiBeckley to Eli Lilly in the biggest acquisition in the industry. "The future is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results